PapersPMID:33030563
The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
What moved
1 findingHow to read these marks →- Decreases serum undercarboxylated osteocalcin concentration
very limitedreplicated ×2
“Undercarboxylated osteocalcin decreased in the MK-7-group (- 65.2 ± 23.5%) (mean ± SD) compared with the placebo group (- 0.03 ± 38.5%), p < 0.01 after 1 year.”
- Study
- RCT
- Duration
- 12 months
- Dose studied
- MK-7 375 µg once daily, added to vitamin D3 38 µg/day and calcium 800 mg/day given to both arms
- Population
- postmenopausal women with osteopenia, both arms receiving vitamin D3 38 µg/day and calcium 800 mg/day; result at 1 year of a 3-year trial
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- postmenopausal women with osteopenia
- Participants
- 142
- Comparator
- placebo
- Duration
- 1,096 days
- Endpoints measured
- 8